Data / Federal grants / HT942526TERPTRA
DoW Toxic Exposures Translational Research Award
Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications until November 19, 2026. It lists 4 awards expected, $6 million in total.
SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.
Key facts
- Opportunity number
- HT942526TERPTRA
- Status
- Posted, open
- Posted
- May 21, 2026
- Closes
- November 19, 2026
- Expected awards
- 4
- Total funding
- $6,000,000
- Cost sharing
- Not required
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Assistance listing
- 12.420 Military Medical Research and Development
- Contact
- Ebony S Simmons Grantor · [email protected] · 301-619-2105
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
What the agency says
Summary: The intent of the fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Translational Research Award (TRA) is to support translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science, or vice versa, in developing and implementing the research plan.
Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP TRA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising ideas into clinical applications. Partnering should significantly advance the research beyond what would be possible through individual efforts.
https://cdmrp.health.mil/pubs/press/2026/terppreann
Other open grants from the Department of Defense
| Opportunity | Status | Closes | Award ceiling | Total funding | Record |
|---|---|---|---|---|---|
| ONR FY27 NOFO for Young Investigator Program N0001426SF004 | Open | Oct 30 | grants.gov | ||
| DoW Bone Marrow Failure, Idea Development Award HT942526BMFRPIDA | Open | Nov 4 | $4,000,000 | grants.gov | |
| DoW Bone Marrow Failure, Investigator-Initiated Research Award HT942526BMFRPIIRA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Bone Marrow Failure, Resource Development Award HT942526BMFRPRDA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Reconstructive Transplant, Concept Award HT942526RTRPCA | Open | Nov 4 | $600,000 | grants.gov | |
| DoW Reconstructive Transplant, Investigator-Initiated Research Award HT942526RTRPIIRA | Open | Nov 4 | $8,000,000 | grants.gov |
All grants open to Anyone (unrestricted) · Everything closing in November 2026
Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.